7:31 am Celgene Board of Directors recommends a two-for-one stock split
moreView todays social media effects on CELGView the latest stocks trending across Twitter. Click to view dashboardSee who Celgene is hiring next, click here to view […]
moreView todays social media effects on CELGView the latest stocks trending across Twitter. Click to view dashboardSee who Celgene is hiring next, click here to view […]
moreView todays social media effects on CELGView the latest stocks trending across Twitter. Click to view dashboardSee who Celgene is hiring next, click here to view […]
[Business Wire] – Celgene Corporation announced that the Board of Directors voted to recommend a two-for-one split of the Company’s common stock to be effected through an Amendment to moreView todays social media effects on CELGView the latest stocks trending across Twitter. Click to view dashboardSee who Celgene is hiring next, click here to view […]
[Business Wire] – Celgene Corporation announced that Celgene management will provide an overview of the Company at three upcoming investor conferences. The conferences will be webcast moreView todays social media effects on CELGView the latest stocks trending across Twitter. Click to view dashboardSee who Celgene is hiring next, click here to view […]
[CNW Group] – Health Canada Approves (Pr)POMALYST(TM) (Pomalidomide Capsules) Providing New Hope For Patients With Progressive Multiple Myeloma moreView todays social media effects on CELGView the latest stocks trending across Twitter. Click to view dashboardSee who Celgene is hiring next, click here to view […]
[at noodls] – Highlights Include Keynote by Nobel Prize Winner, Dr. John Gurdon New York, March 21, 2013 — The Stem for Life Foundation, NeoStem, Inc. (NYSE MKT:NBS), The Pontifical Council for Culture, and STOQ International … moreView todays social media effects on CELGView the latest stocks trending across Twitter. Click to view dashboardSee who Celgene is hiring next, click […]
[Business Wire] – BOUDRY, Switzerland–(BUSINESSWIRE)– Celgene International Sà rl, a subsidiary of Celgene Corporation (NASDAQ: CELG), today announced that REVLIMID ® (lenalidomide) has been granted full approval, which … moreView todays social media effects on CELGView the latest stocks trending across Twitter. Click to view dashboardSee who Celgene is hiring next, click here to view […]
[ACN Newswire] – By Ivan DeryuginThe biotechnology sector can be broken up, at its simplest, into two distinct groups: the Big 4, and every other company. The Big 4 are Amgen (NASDAQ:AMGN), Celgene (NASDAQ:CELG), Gilead … moreView todays social media effects on CELGView the latest stocks trending across Twitter. Click to view dashboard […]
[ACN Newswire] – By Jake KingIn separate press releases on Thursday morning, Celgene (NASDAQ:CELG) reported 3Q results and announced that Abraxane demonstrated a statistically significant improvement in Progression Free … moreView todays social media effects on CELGView the latest stocks trending across Twitter. Click to view dashboard […]
[ACN Newswire] – By Jake KingCelgene (NASDAQ:CELG) moved closer today to securing another indication for its oncology drug, Abraxane, which is already approved as a second-line treatment for metastatic breast cancer. On … moreView todays social media effects on CELGView the latest stocks trending across Twitter. Click to view dashboard […]